Dua Putra Utama Makmur Tbk. vs Merck Tbk. — how do they compare? Dua Putra Utama Makmur Tbk. trades at Rp99 (market cap 409.15B, 2.61M 24h volume), while Merck Tbk. trades at Rp3,830 (market cap 1.7T, 13.7K 24h volume). The key difference: Merck Tbk. is far larger — about 4.2× Dua Putra Utama Makmur Tbk.'s market cap, and Dua Putra Utama Makmur Tbk. is more actively traded (2.61M versus 13.7K). Which is the better fit depends on your goals.
| DPUM | MERK | |
|---|---|---|
Market Cap | 409.15B | 1.7T |
Volume | 2.61M | 13.7K |
Lot | 26.13K | 137 |
Turnover | 256.62M | 52.45M |
Average Price | 98.21 | 3,828.69 |
Value | 256.62M | 52.45M |
Indicative Equilibrium Price | 98 | 3,850 |
Indicative Equilibrium Volume | 156.2K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Dua Putra Utama Makmur Tbk (the Entity) was established under the name PT Dua Putra Utama Makmur based on Notarial Deed of Sugiyono, S.H., No. 8, dated May 9, 2012.
Read more on DPUM →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →